Control Bionics' US Business Logs Record Revenue in Fiscal Q2

MT Newswires Live

2025/02/03

Control Bionics' (ASX:CBL) US business reported record revenue of nearly $1 million in the fiscal second quarter ended December 2024, according to a Jan. 31 filing with the Australian bourse.

Cash receipts surpassed AU$1.4 million, representing an almost 30% year-on-year rise on the back of strong US sales and improving National Disability and Insurance Scheme approvals, per the filing.

Elsewhere, the medical device company logged its first sales in the UK and Ireland following the Smart Box distribution agreement.

Control Bionics reported net cash outflows of AU$1.7 million for the fiscal Q2.

The company said it is "positioned for strong growth" in the second half of the fiscal year.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2508169901"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2508169901\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2508169901?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-03 11:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2508169901","market":"sh","top_or_hot":-1,"title":"Control Bionics' US Business Logs Record Revenue in Fiscal Q2","media":"MT Newswires Live","content":"<html><body><p> Control Bionics' (ASX:CBL) US business reported record revenue of nearly $1 million in the fiscal second quarter ended December 2024, according to a Jan. 31 filing with the Australian bourse.</p><p>Cash receipts surpassed AU$1.4 million, representing an almost 30% year-on-year rise on the back of strong US sales and improving National Disability and Insurance Scheme approvals, per the filing.</p><p>Elsewhere, the medical device company logged its first sales in the UK and Ireland following the Smart Box distribution agreement.</p><p>Control Bionics reported net cash outflows of AU$1.7 million for the fiscal Q2.</p><p>The company said it is \"positioned for strong growth\" in the second half of the fiscal year.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Control Bionics' US Business Logs Record Revenue in Fiscal Q2</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nControl Bionics' US Business Logs Record Revenue in Fiscal Q2\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-02-03 11:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Control Bionics' (ASX:CBL) US business reported record revenue of nearly $1 million in the fiscal second quarter ended December 2024, according to a Jan. 31 filing with the Australian bourse.</p><p>Cash receipts surpassed AU$1.4 million, representing an almost 30% year-on-year rise on the back of strong US sales and improving National Disability and Insurance Scheme approvals, per the filing.</p><p>Elsewhere, the medical device company logged its first sales in the UK and Ireland following the Smart Box distribution agreement.</p><p>Control Bionics reported net cash outflows of AU$1.7 million for the fiscal Q2.</p><p>The company said it is \"positioned for strong growth\" in the second half of the fiscal year.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CBL.AU","symbol_name":"Control Bionics Ltd","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2508169901","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2508169901","pubTimestamp":1738551832,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Control Bionics'  US business reported record revenue of nearly $1 million in the fiscal second quarter ended December 2024, according to a Jan. 31 filing with the Australian bourse.Cash receipts surpassed AU$1.4 million, representing an almost 30% year-on-year rise on the back of strong US sales and improving National Disability and Insurance Scheme approvals, per the filing.Elsewhere, the medical device company logged its first sales in the UK and Ireland following the Smart Box distribution agreement.Control Bionics reported net cash outflows of AU$1.7 million for the fiscal Q2.The company said it is \"positioned for strong growth\" in the second half of the fiscal year.","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"CBL.AU":"Control Bionics Ltd"},"translate_title":"Control Bionics美国业务第二财季收入创历史新高","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CBL.AU":0.9},"content_text":"Control Bionics' (ASX:CBL) US business reported record revenue of nearly $1 million in the fiscal second quarter ended December 2024, according to a Jan. 31 filing with the Australian bourse.Cash receipts surpassed AU$1.4 million, representing an almost 30% year-on-year rise on the back of strong US sales and improving National Disability and Insurance Scheme approvals, per the filing.Elsewhere, the medical device company logged its first sales in the UK and Ireland following the Smart Box distribution agreement.Control Bionics reported net cash outflows of AU$1.7 million for the fiscal Q2.The company said it is \"positioned for strong growth\" in the second half of the fiscal year.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}